Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pankhuree Vandana

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Review of Neurotherapeutics|March 16, 2019
Dasotraline in ADHD: novel or me too drug?Pankhuree Vandana, Eugene Arnold
Journal of the American Academy of Child and Adolescent Psychiatry|May 28, 2023
Editorial: Failing in our Responsibility to Address Obesity Caused by Psychotropic MedicationsPankhuree Vandana, Jeremy Veenstra-VanderWeele
Child and Adolescent Psychiatric Clinics of North America|May 5, 2023
Autism Spectrum Disorder and Complementary-Integrative MedicinePankhuree Vandana, Deborah R Simkin, Robert L Hendren, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|January 10, 2020
When to Raise Our White Flag-A Discussion of Scope of Practice in a Resource Scarce WorldElizabeth Barnhardt, Rebecca Baum, Mark Winerman, et al.
Journal of Autism and Developmental Disorders|May 16, 2022
Incorporation of Telepsychiatry for Patients with Developmental Disorders into Routine Clinical Practice-A Survey of Specialty Clinics Adapting to Telepsychiatry During the COVID-19 PandemicShikha Verma, Pankhuree Vandana, Takahiro Soda, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 26, 2026
Novel therapeutics in autism spectrum disorderSara Daniella Kevelson, Rana Elmaghraby, Fenil Patel, et al.
European Child & Adolescent Psychiatry|June 4, 2023
The stability and persistence of symptoms in childhood-onset ADHDAnna R Van Meter, Margaret H Sibley, Pankhuree Vandana, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Review of Neurotherapeutics|March 16, 2019
Dasotraline in ADHD: novel or me too drug?Pankhuree Vandana, Eugene Arnold
Journal of the American Academy of Child and Adolescent Psychiatry|May 28, 2023
Editorial: Failing in our Responsibility to Address Obesity Caused by Psychotropic MedicationsPankhuree Vandana, Jeremy Veenstra-VanderWeele
Child and Adolescent Psychiatric Clinics of North America|May 5, 2023
Autism Spectrum Disorder and Complementary-Integrative MedicinePankhuree Vandana, Deborah R Simkin, Robert L Hendren, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|January 10, 2020
When to Raise Our White Flag-A Discussion of Scope of Practice in a Resource Scarce WorldElizabeth Barnhardt, Rebecca Baum, Mark Winerman, et al.
Journal of Autism and Developmental Disorders|May 16, 2022
Incorporation of Telepsychiatry for Patients with Developmental Disorders into Routine Clinical Practice-A Survey of Specialty Clinics Adapting to Telepsychiatry During the COVID-19 PandemicShikha Verma, Pankhuree Vandana, Takahiro Soda, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 26, 2026
Novel therapeutics in autism spectrum disorderSara Daniella Kevelson, Rana Elmaghraby, Fenil Patel, et al.
European Child & Adolescent Psychiatry|June 4, 2023
The stability and persistence of symptoms in childhood-onset ADHDAnna R Van Meter, Margaret H Sibley, Pankhuree Vandana, et al.
Pageof 1